A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2012

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

Imexon + docetaxel

Imexon at 1300 mg/m2 days 1-5 Docetaxel at 75 mg/m2 day 1

Trial Locations (3)

USC Norris Cotton Cancer Center, Los Angeles

Massachusetts General Hospital, Boston

Mary Crowley Research Center, Dallas